United Therapeutics (UTHR), MannKind (MNKD) Announces FDA Acceptance of Tyvaso DPI NDA For Priority Review

Go back to United Therapeutics (UTHR), MannKind (MNKD) Announces FDA Acceptance of Tyvaso DPI NDA For Priority Review

MannKind (MNKD) Climbs 20% Pre-Open

June 16, 2021 6:28 AM EDT

MannKind (NASDAQ: MNKD) Climbs 20% Pre-Open

Earlier United Therapeutics (UTHR), MannKind (MNKD) Announces FDA Acceptance of Tyvaso DPI NDA For Priority Review


... More